No summary has been written for this.
Amplify Weight Loss Drug & Treatment ETF is an exchange-traded fund designed to provide exposure to global companies involved in the development, commercialization, and supporting ecosystem of weight loss drugs and treatments. The fund seeks to track the VettaFi Weight Loss Drug & Treatment Index, using a rules-based approach that targets businesses expected to benefit economically from GLP-1-related therapies and the broader supply chain around these medicines. Its portfolio spans healthcare and pharmaceutical companies across developed and global markets, including drug developers, manufacturers, and firms that enable treatment distribution and related services. THNR offers a focused, thematic equity strategy for investors seeking diversified access to a specialized segment of the healthcare market centered on obesity treatment innovation and associated industry participants.
The latest articles about THNR.
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
No summary yet.